» Articles » PMID: 24194916

The Landscape of Candidate Driver Genes Differs Between Male and Female Breast Cancer

Overview
Journal PLoS One
Date 2013 Nov 7
PMID 24194916
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The rapidly growing collection of diverse genome-scale data from multiple tumor types sheds light on various aspects of the underlying tumor biology. With the objective to identify genes of importance for breast tumorigenesis in men and to enable comparisons with genes important for breast cancer development in women, we applied the computational framework COpy Number and EXpression In Cancer (CONEXIC) to detect candidate driver genes among all altered passenger genes. Unique to this approach is that each driver gene is associated with several gene modules that are believed to be altered by the driver. Thirty candidate drivers were found in the male breast cancers and 67 in the female breast cancers. We identified many known drivers of breast cancer and other types of cancer, in the female dataset (e.g. GATA3, CCNE1, GRB7, CDK4). In contrast, only three known cancer genes were found among male breast cancers; MAP2K4, LHP, and ZNF217. Many of the candidate drivers identified are known to be involved in processes associated with tumorigenesis, including proliferation, invasion and differentiation. One of the modules identified in male breast cancer was regulated by THY1, a gene involved in invasion and related to epithelial-mesenchymal transition. Furthermore, men with THY1 positive breast cancers had significantly inferior survival. THY1 may thus be a promising novel prognostic marker for male breast cancer. Another module identified among male breast cancers, regulated by SPAG5, was closely associated with proliferation. Our data indicate that male and female breast cancers display highly different landscapes of candidate driver genes, as only a few genes were found in common between the two. Consequently, the pathobiology of male breast cancer may differ from that of female breast cancer and can be associated with differences in prognosis; men diagnosed with breast cancer may consequently require different management and treatment strategies than women.

Citing Articles

HER2 expression and pathway status in male breast cancer patients: results of an integrated analysis among 6,150 patients.

Lyu B, Zhao S, Wang H, Gong S, Wang B Sci Rep. 2025; 15(1):3354.

PMID: 39870698 PMC: 11772752. DOI: 10.1038/s41598-025-86556-0.


Deciphering the molecular landscape: evolutionary progression from gynecomastia to aggressive male breast cancer.

Yang C, Wang Z, Qian L, Fu J, Sun H Cell Oncol (Dordr). 2024; 47(5):1831-1843.

PMID: 38888848 DOI: 10.1007/s13402-024-00964-4.


Demographics, Characteristics, and Outcomes of Male Breast Cancer Patients at the Methodist Health System, Dallas, USA.

Nong H, Eastwood D, Rodriguez K, Puri V Cureus. 2023; 15(11):e49394.

PMID: 38146568 PMC: 10749682. DOI: 10.7759/cureus.49394.


Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.

Al Saati A, Vande Perre P, Plenecassagnes J, Gilhodes J, Monselet N, Cabarrou B Int J Mol Sci. 2023; 24(18).

PMID: 37762649 PMC: 10531866. DOI: 10.3390/ijms241814348.


Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers.

Kim H, Wisniewska K, Regner M, Thennavan A, Spanheimer P, Franco H Int J Mol Sci. 2023; 24(17).

PMID: 37685859 PMC: 10487538. DOI: 10.3390/ijms241713053.


References
1.
Rege T, Hagood J . Thy-1 as a regulator of cell-cell and cell-matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB J. 2006; 20(8):1045-54. DOI: 10.1096/fj.05-5460rev. View

2.
Cheng B, Jiang Y, Li D, Fan J, Ma M . Up-regulation of thy-1 promotes invasion and metastasis of hepatocarcinomas. Asian Pac J Cancer Prev. 2012; 13(4):1349-53. DOI: 10.7314/apjcp.2012.13.4.1349. View

3.
Korde L, Zujewski J, Kamin L, Giordano S, Domchek S, Anderson W . Multidisciplinary meeting on male breast cancer: summary and research recommendations. J Clin Oncol. 2010; 28(12):2114-22. PMC: 2860409. DOI: 10.1200/JCO.2009.25.5729. View

4.
Nilsson C, Koliadi A, Johansson I, Ahlin C, Thorstenson S, Bergkvist L . High proliferation is associated with inferior outcome in male breast cancer patients. Mod Pathol. 2012; 26(1):87-94. DOI: 10.1038/modpathol.2012.145. View

5.
Dutta B, Pusztai L, Qi Y, Andre F, Lazar V, Bianchini G . A network-based, integrative study to identify core biological pathways that drive breast cancer clinical subtypes. Br J Cancer. 2012; 106(6):1107-16. PMC: 3304402. DOI: 10.1038/bjc.2011.584. View